The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

MRVI FINANCIAL STATEMENTS

Maravai Lifesciences Holdings Inc — balance sheet, income statement and cash flow trends

MRVIMaravai Lifesciences Holdings Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0500 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue208.8 M $Gross Profit72.2 M $ · 35%Operating Income96.1 M $ · 46%Pre-tax Income-136.5 M $ · -65%Net Income to Owners-77.4 M $ · -37%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue208.8 M $-3.3%
Gross Profit72.2 M $+15.0%
Operating Income96.1 M $—
EBITDA-57.2 M $—
Net Income to Owners-77.4 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
01 B2 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets603.7 M
  • Equity204.6 M $45%
  • Current Liabilities38.4 M $8%
  • Long-term Liabilities209.7 M $46%

Key Figures

YoY change
Total Assets603.7 M $-32.7%
Total Liabilities248.2 M $-42.2%
Total Equity204.6 M $-23.0%
Cash & ST Investments70.1 M $-74.0%
Total Debt176.7 M $-51.4%
Net Debt106.6 M $+13.8%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0200 M400 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-200 M-100 M0-25.3 M $Operating-9.8 M $Investing-164.3 M $Financing-199.4 M $Net Change

Key Figures

YoY change
Operating Cash Flow-25.3 M $—
Capital Expenditures9.8 M $-58.2%
Free Cash Flow-35.1 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on MRVI

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 23, 26. This content is for informational purposes only and is not investment advice.